期刊文献+

ⅡB期宫颈鳞癌不同方案同步放化疗与单纯放疗的疗效及毒副反应比较 被引量:1

Analysis of the efficacy and toxicities of concurrent chemoradiotherapy and radiotherapy alone in the treatment of stage ⅡB cervical squamous cell carcinoma
下载PDF
导出
摘要 目的比较ⅡB期宫颈鳞癌单纯放疗、单药顺铂(P方案)同步放化疗、顺铂联合多西他赛(TP方案)同步放化疗的疗效及毒副反应。方法收集收治的ⅡB期宫颈鳞癌患者112例,34例选择单纯放疗,78例选择同步放化疗的患者按入院顺序随机分为P方案同步放化疗组(40例)和TP方案同步放化疗组(38例)。3组患者均给予相同的根治性放疗,P方案同步放化疗组在放疗第l、8、15、22、29天给予顺铂40 mg·(m2)-1静脉滴注;TP方案同步放化疗组在放疗第l、22天给予多西他赛75 mg·(m2)-1、顺铂50 mg·(m2)-1静脉滴注。结果单纯放疗组、P方案同步放化疗组、TP方案同步放化疗组,完全缓解率(CR)分别为82.35%、95.00%、92.11%;3年生存率分别为81.70%、94.60%、83.20%(P<0.05);3年无病生存率分别为69.10%、86.10%、77.50%(P<0.05)。单纯放疗组、P方案同步放化疗组、TP方案同步放化疗组≥3级白细胞下降发生率分别为32.35%、42.50%、52.63%(P>0.05);2级恶心、呕吐发生率分别为29.41%、27.50%、55.26%(P<0.05)。结论ⅡB期宫颈鳞癌同步放化疗与单纯放疗比较,有效率及生存率均有提高趋势,同步放化疗P方案较TP方案更易耐受。 Objective To compare the efficacy and toxicities of single agent cisplatin (P) and cisplatin - docetaxe (TP) con- current chemoradiotherapy and radiotherapy alone in the treatment of stage ⅡB cervical squamous cell carcinoma. Methods 112 pa- tients with stage ⅡB cervical squamous cell carcinoma were registered. 78 patients were randomly divided into P group (n = 40) and TP group ( n = 38 ). 34 patients who refused chemotherapy received radiotherapy alone. The same radiotherapy modality were delivered to all patients. Single agent cisplatin was given in a dose of 40 mg · ( m2 ) -l at day of 1,8,15,22 and 29. In the TP group ,doeetaxe and cispla- tin were given in a dose of 75 mg · (m2) -1 ,50 mg· (m2) -1 at day of 1 and 22. Results The CR rates were respectively 82.35%, 95.00% and 92.11% in the radiotherapy alone group,P group and TP group,81.70% ,94.60% and 83.20% for 3 -year survival rates ( X2 = 1.114 ,P 〉 0.05 ;3 - year disease free survival rates were 69.10% ,86.10% and 77.50% ( X2 = 0. 701 ,P 〉 0.05 ). The incidence of grade 3 hematological toxicity were 32.35% ,42.50% and 52.63% in the radiotherapy alone group ,P group and TP group respective- ly,29.41% ,27.50% and 55.26% ( X2 = 7. 882,P 〈 0.05 ) for grade 2 gastrointestinal toxicity. Conclusion Comparing with radiother- apy alone, chemoradiotherapy trend to improve the overall survival and disease free survival rates of stage ⅡB cervical squamous cell car- cinoma. Single agent cisplatin is a little more efficacious and less toxic compared with TP regimen.
出处 《宁夏医学杂志》 CAS 2014年第4期311-313,I0001,共4页 Ningxia Medical Journal
基金 宁夏科技攻关计划项目(201125)
关键词 宫颈肿瘤 放射疗法 同步放化疗 Cervical cancer Irradiation Concurrent chemoradiotherapy
  • 相关文献

参考文献10

  • 1Jemal A, Bray F, Center MM, et al. Global cancer statistics [ J ]. CA Cancer J Clin,2011,61:69 -90.
  • 2Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chem- otherapy compared with pelvic and para - aortic radiation for high - risk cervical cancer [ J ]. The New England Journal of Medicine, 1999,340(15) :1137 - 1143.
  • 3Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin - based radiotherapy and chemotherapy for locally advanced cervical cancer [ J ]. The New England Journal of Medicine, 1999,340 ( 15 ) : 1144.
  • 4Pecorelli S,Zigliani L,Odicino F. Revised FIGO staging for carcinoma of the cervix[J]. Int J Gynaecol Obstet ,2009,105 ( 2 ) : 107 - 108.
  • 5Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment[ J]. Cancer, 1981,47 ( l ) :207 - 214.
  • 6Pearcey R, Miao Q, Kong W, et al. Impact of adoption of chemora- diotherapy on the outcome of cervical cancer in Ontario : results of a population- based cohort study [ J ]. J Clin Oncol, 2007,25 (17 ) : 2383 - 2388.
  • 7Bridgewater J. Combined chemotherapy and radiation for locally ad- vanced cervical carcinoma [ J ]. Clinical Oncology, 1998,10:78.
  • 8Rose PG,Ali S,Watkins E,et al. Long -term follow -up of a ran- domized trial comparing concurrent single agent cisplatin, cisplatin - based combination chemotherapy, or hydroxyurea during pelvic ir- radiation for locally advanced cervical cancer: a gynecologic oncolo- gy group study[ J]. J Clin Onco1,2007,25 (19) :2804 -2810.
  • 9潘素明,陈志仁,余晓文,丘全胜.单药奈达铂和PF方案在局部晚期宫颈癌同步放化疗中的疗效及毒副反应对比分析[J].肿瘤基础与临床,2011,24(1):32-34. 被引量:23
  • 10Kim YS, Shin SS, Nam JH, et al. Prospective randomized compari- son of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high -dose rate brachy- therapy for locally advanced cervical cancer [ J ]. Gyneeol Oncol, 2008,108 ( 1 ) : 195 - 200.

二级参考文献9

  • 1黄曼妮,吴令英,高菊珍.宫颈癌的同步放化疗[J].癌症进展,2004,2(5):320-326. 被引量:60
  • 2管忠震,徐瑞华.奈达铂临床研究进展[J].中国肿瘤临床,2004,31(13):774-780. 被引量:176
  • 3余健,张国楠,樊英.同步放化疗治疗中晚期宫颈癌50例临床疗效观察[J].实用妇产科杂志,2007,23(5):287-289. 被引量:74
  • 4连丽娟.林巧稚妇科肿瘤学[M].4版,北京:人民卫生出版社,2006:831.
  • 5Rose PG,Bundy BN,Watkins EB,et al.Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer[J].N Engl J Med,1999,340(15):1144-1153.
  • 6Bridgewater J.Combined chemotherapy and radiation for locally advanced cervical carcinoma[J].Clin Oncol (R Coll Radiol),1998,10(2):78 -83.
  • 7Arai T,Nakano T,Morita S,et al.High dose rate after loading intracavitary radiation therapy for cancer of the uterine cervix[J].Cancer,2003,69(1):175.
  • 8Green JA,Kirwan JM,Tiemey JF,et al.Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix:a systematic review and meta-analysis[J].Lancet,2001,358(9284):781 -786.
  • 9李继东,王舒,肖永久,金远林,朱运奎.国产奈达铂联合吉西他滨治疗晚期非小细胞肺癌[J].实用医学杂志,2008,24(5):811-812. 被引量:30

共引文献22

同被引文献32

  • 1盛群英,潘雪珍,刘力,李华美,刘江英.手术加综合治疗与同步放化疗治疗ⅡB期宫颈癌的比较[J].华西医学,2009,24(12):3196-3197. 被引量:1
  • 2李秀华,冯梅,陈国英.88例Ⅱ_b期宫颈癌临床治疗分析[J].福建医药杂志,2005,27(4):15-16. 被引量:1
  • 3谭道彩,粱立治,彭小萍.Ⅱb期宫颈癌的治疗[J].现代妇产科进展,1995,4(2):131-132. 被引量:1
  • 4李玲,隋丽华.IIb期子宫颈癌患者术前动脉插管化疗的十年观察[J].中华妇产科杂志,1989,24(1):37-39. 被引量:19
  • 5田桂兰.手术治疗Ⅱb期宫颈癌的疗效评价[J].第三军医大学学报,2006,28(7):738-738. 被引量:2
  • 6Jemal A, Bray F, Center MM, et al. Global cancer statistics [J]. CA Cancer J Clin, 2011,6(2) : 69-90.
  • 7National Comprehensive Cancer Network. The NCCN soft tissue sarcoma clinical practice guidelines in oncology (version 1.2014) [EB/OL]. Fort Washington: National Comprehensive Cancer Network,2014 [2014-03-14]. http://www.nccn.org/professionals/ physician_gls/f_guidelines.asp.
  • 8Chauvergne J, Rohart J, Heron JF, et al. Randomized phase III trial of neoadjuvant chemotherapy (CT) radiotherapy (RT) vs RT in stage IIB, III carcinoma of the cervix (CACX): A cooperative study of the French oncology centers[J]. Proc Am Soc Clin Oncol, 1988,7 : 136.
  • 9Tattersal MH,Ramirez C,Dalrymple C,et al. A randomized trial comparing cisplatin based chemotherapy followed by radiotherapy versus radiotherapy alone in patients with stage IIB-IVA cervical cancer[J]. Proc Int Gynecol Cancer Soc, 1991,1:44.
  • 10Quinn MA,Benedet JL,Odicino F,et al. Carcinoma of the cervix uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer[J]. Int J Gynaeeol Obstet, 2006,95 (Suppl 1 ) : S43-S 103.

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部